Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/1996
05/29/1996CN1123185A Immune couplet
05/29/1996CN1123184A Gelling cosmetic and/or skin using composition containing dissolvant and hollow particles
05/29/1996CN1123147A Iron-supplementing preparation capable of permeating skin and preparation method thereof
05/29/1996CN1123142A Fluoxetine pahrmaceutical formulations
05/29/1996CN1031862C Process for preparation of pharmaceutical composition
05/28/1996US5521291 Adenovirus conjugates for gene therapy
05/28/1996US5521290 Reaction of maleimide groups of bifunctional linking compounds with molecules to be linked, then reacting remaining aldehyde and hydrazide groups of linking compounds
05/28/1996US5521289 Small organometallic probes
05/28/1996US5521063 Polynucleotide reagent containing chiral subunits and methods of use
05/28/1996US5520927 Method for the preparation of sustained release somatotropin and product produced thereby
05/28/1996US5520924 Methods and articles for administering drug to the oral cavity
05/28/1996US5520923 Formulations for delivery of osteogenic proteins
05/28/1996US5520920 Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions
05/28/1996CA2078996C A bifunctional dtpa-type ligand
05/28/1996CA2041330C Percutaneously absorbable eperisone or tolperisone preparation
05/28/1996CA2000401C Percutaneous pharmaceutical preparation
05/23/1996WO1996015234A2 Lipid-splitting enzyme
05/23/1996WO1996015146A1 Conjugates of bdnf and nt-3 with a water-soluble polymer
05/23/1996WO1996014881A1 Inclusion complex of a radiohalogenated fatty acid in a cyclodextrin
05/23/1996WO1996014879A1 Methods for use of novel lyoprotectants and instant kit formulations for radiopharmaceuticals using the same
05/23/1996WO1996014876A1 Yeast-based delivery vehicles
05/23/1996WO1996014874A1 Method for gene therapy involving suppression of an immune response
05/23/1996WO1996014873A2 COVALENTLY BOUND β-GLUCAN CONJUGATES IN TARGETED DELIVERY
05/23/1996WO1996014872A1 Novel complexes and their compositions
05/23/1996WO1996014871A1 Immunogenic compositions
05/23/1996WO1996014870A1 Composition, device, and method for enhanced electrotransport agent delivery
05/23/1996WO1996014869A1 Composition, device, and method for electrotransport agent delivery
05/23/1996WO1996014858A1 Use of angiotensin ii fragments and analogs thereof in tissue repair
05/23/1996WO1996014850A1 Decolorized carotenoid-cyclodextrin complexes
05/23/1996WO1996014841A1 Antiviral and antitumor pharmaceutical compositions
05/23/1996WO1996014839A1 Pharmaceutical composition comprising non-steroidal anti-inflammatory drugs
05/23/1996WO1996014838A1 Novel diacetyldapsone-containing compositions and the use thereof for the treatment of various disease states
05/23/1996WO1996014832A1 Synthetic liposomes for enhanced uptake and delivery
05/23/1996WO1996014831A1 Adjuvant for a vaccine composition
05/23/1996WO1996014829A1 Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
05/23/1996WO1996014828A1 Hemorrhoidal compositions and method of use
05/23/1996WO1996011054A3 Process for the preparation of microspheres and microspheres made thereby
05/23/1996WO1996007440A3 Methods and apparatus for the delivery of solid drug compositions
05/23/1996WO1995034308A3 Adjuvant compositions comprising a mineral salt and another immunostimulating compound
05/23/1996CA2205385A1 Pharmaceutical composition comprising non-steroidal anti-inflammatory drugs
05/23/1996CA2205360A1 Methods for use of novel lyoprotectants and instant kit formulations for radiopharmaceuticals using the same
05/23/1996CA2205083A1 Immunogenic compositions
05/23/1996CA2205019A1 Novel complexes and their compositions
05/23/1996CA2204908A1 Lipid cleavage enzyme
05/22/1996EP0712635A1 Medical polymer gel
05/22/1996EP0712633A1 Pharmaceutical compositions for topical application
05/22/1996EP0712631A2 Cyclosporin containing multiple emulsions
05/22/1996EP0712421A1 Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
05/22/1996EP0712389A1 Therapeutic compound - fatty acid conjugates
05/22/1996EP0712330A1 Concentrated aqueous compositions of alkylpolyglycosides, and applications thereof
05/22/1996EP0712314A1 Monogenous preparations of cytotoxic conjugates
05/22/1996EP0712313A1 Pro-cytotoxic drug conjugates for anticancer therapy
05/22/1996EP0712293A1 Methods of preparing gas and gaseous precursor-filled microspheres
05/22/1996EP0486526B1 Tumour necrosis factor binding ligands
05/22/1996EP0454735B1 Vaccine composition
05/22/1996CN1123030A Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, its preparation and use
05/22/1996CN1123005A Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and nsaid
05/22/1996CN1122719A Chewing pieces of Jin'gui shenqi Wan and prepn. method thereof
05/22/1996CN1122718A Chewing pieces of Buzhong Yiqi Wan and prepn. method thereof
05/22/1996CN1122697A Chewing medicinal piece of Qi Ju Dihuang Wan and prepn. method thereof
05/22/1996CN1122689A Chewing medicinal piece of shiquan dabu Wan and the prepn. method
05/21/1996US5519059 Of isopropyl alcohol, isopropyl myristate, polyoxyethylene glycol and tolnaftate
05/21/1996US5519020 Polymer adducts which release nitric oxide
05/21/1996US5519012 Inclusion complexes of optically active 1,4-dihydropyridines with methyl-β-cyclodextrin
05/21/1996US5519009 Interleukins
05/21/1996US5518998 Therapeutic preparation for inhalation
05/21/1996US5518902 High pullulan content product, and its preparation and uses
05/21/1996US5518888 Imaging metastasized colorectal cancer, toxtin peptides less than 25 units
05/21/1996US5518738 Nanoparticulate nsaid compositions
05/21/1996US5518736 Method of preparing natural-oil-containing emulsions and microcapsules and its uses
05/21/1996US5518734 Transdermal delivery system for estradiol and process for manufacturing said device
05/21/1996US5518732 Bio-erodible ophthalmic shield
05/21/1996US5518730 Biodegradable controlled release flash flow melt-spun delivery system
05/21/1996US5518718 Nonirritating nonionic tissue cleaning compositions
05/21/1996US5518711 X-ray contrast medium comprising barium and xanthan gum for examination of large intestine and small intestine
05/21/1996CA2127111C A method for preparing enteric-coated oral drugs containing acid-unstable compounds
05/21/1996CA1338344C Stabilized medicinal substances, a process for the preparation thereof, and stable medicinal formulations
05/21/1996CA1338337C Method and composition for the treatment of burns
05/17/1996WO1996014339A1 Antibodies
05/17/1996WO1996014282A1 Polyol composition produced by co-spray-drying
05/17/1996WO1996014090A1 Compositions comprising carbazoles and cyclodextrins
05/17/1996WO1996014087A1 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector
05/17/1996WO1996014086A1 Combined meningitis vaccine
05/17/1996WO1996014083A1 Application of superoxide dismutase in liposomes
05/17/1996WO1996014079A1 Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them
05/17/1996WO1996014070A1 Cisapride extended release oral compositions
05/17/1996WO1996014069A1 Percutaneously absorbable patch
05/17/1996WO1996014062A1 A delivery system for antimethanogenic agents
05/17/1996WO1996014059A1 Pharmaceutical composition containing a fusible carrier and method for producing the same
05/17/1996WO1996014058A1 Melt-extruded orally administrable opioid formulations
05/17/1996WO1996014056A1 Use of liquid fluorocarbons to facilitate pulmonary drug delivery
05/17/1996WO1996007398A3 Sustained release of peptides from pharmaceutical compositions
05/17/1996CA2689871A1 Combined meningitis vaccine
05/17/1996CA2204358A1 A delivery system for antimethanogenic agents
05/17/1996CA2180664A1 Polyol composition produced by co-spray-drying
05/15/1996EP0711557A1 Base for formulating pharmaceutical agents
05/15/1996EP0711556A1 Intravenous solutions containing staurosporine derivatives
05/15/1996EP0711555A2 Enzyme inactivators
05/15/1996EP0711551A2 Percutaneous absorption preparation
05/15/1996EP0711550A1 Cyclosporin-containing soft capsule compositions
1 ... 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 ... 1712